NCT05376046 Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA) Status RECRUITING Phase N/A
NCT05371184 Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients Status COMPLETED Phase PHASE4
NCT05353647 A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05348915 A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT05336201 Cognitive Remediation Intervention to Prepare for Transition of Care Status RECRUITING Phase PHASE2
NCT05334576 Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA Status UNKNOWN Phase NA
NCT05329649 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05289700 Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) Status UNKNOWN Phase PHASE3
NCT05285917 Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa Status RECRUITING Phase PHASE3
NCT05261711 AB1 in Adult Patients with Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE1/PHASE2
NCT05255445 Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients Status COMPLETED Phase N/A
NCT05253781 Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE) Status COMPLETED Phase PHASE3
NCT05249452 Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients Status COMPLETED Phase N/A